India’s bioeconomy was worth about $10 billion in 2014. It’s now worth roughly $195 billion, and NITI Aayog just published a plan to push it past $2.6 trillion by 2047.
mcqquestion.com
Indian Economy · IndEco0199
Bioeconomy Roadmap 2035
NITI Aayog’s 10-year plan for a biotech powerhouse
$691B
bioeconomy target by 2035
$2.6T
target by 2047
30M+
high-value jobs targeted
6 National BioMissions
GeneIndia
AgriBio 2.0
BioX Foundry
One Health Grid
Marine Biotech
BioPharmaNext
From $10B to $691B, in one generation
India’s bioeconomy grew from about $10 billion in 2014 to roughly $195 billion today. The Roadmap bets that growth curve can steepen further, not just continue.
Must Know
- On 16 July 2026, NITI Aayog launched the “Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035.”
- The Roadmap was launched by Dr. Jitendra Singh, Minister of State (Independent Charge) for Science and Technology.
- It targets a bioeconomy worth $691 billion by 2035, and $2.6 trillion by 2047.
- The Roadmap aims to create over 30 million high-value jobs.
- It was developed by the NITI Frontier Tech Hub, in consultation with the Department of Biotechnology (DBT), industry body ABLE, academia, and other stakeholders.
- The Roadmap proposes a ₹50,000 crore BioEconomy Growth Fund.
Good to Know
- India’s bioeconomy grew from about $10 billion in 2014 to over $195 billion today.
- The Roadmap proposes 6 National BioMissions: GeneIndia, AgriBio 2.0, BioX Foundry, One Health Grid, Marine Biotechnology, and BioPharmaNext.
- These missions cover gene and cell therapies, climate-resilient agriculture, synthetic biology, disease surveillance, marine biotechnology, and next-generation biopharmaceuticals.
- Beyond the Growth Fund, the Roadmap also recommends faster regulatory approvals, AI-led biotechnology research, and stronger industry-academia collaboration.
- The Roadmap was launched in the presence of Prof. Gobardhan Das, Member, NITI Aayog. His name is a coincidental match to the unrelated GOBARdhan scheme.
- The Roadmap positions India among the world’s leading biotechnology powers, alongside the US and China.
Test Yourself
Great to Know
- This national Roadmap is much broader than IndEco0118 — GOBARdhan, which focuses narrowly on circular bioenergy from cattle dung and organic waste. GOBARdhan is one small piece of the much larger bioeconomy this Roadmap targets.
- The Department of Biotechnology’s direct role in shaping this Roadmap connects to its own institutional story. See SciTech0112 — DBT and BRCP.
- Naming 6 separate missions, rather than one single programme, follows a pattern India has used before. It broke earlier big bets, like the National Quantum Mission and its semiconductor push, into named, trackable sub-programmes too.
- A $10 billion to $195 billion jump in roughly a decade already outpaces many other Indian sectors. The Roadmap’s $691 billion 2035 target assumes that pace can accelerate further, not just hold steady.
Leave a Reply